Charlotte Colosio
YOU?
Author Swipe
View article: Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study
Biopsy-Proven T-Cell Mediated Rejection After Belatacept Rescue Conversion: A Multicenter Retrospective Study Open
After kidney transplantation, conversion to belatacept is a promising alternative in patients with poor graft function or intolerance to calcineurin inhibitors. The risk of acute rejection has not been well described under these conditions…
View article: Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft
Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft Open
Background Recurrence of focal segmental glomerulosclerosis (FSGS) is common after kidney transplantation and is classically associated with a significant decrease in graft survival. A major risk factor is a prior history of FSGS recurrenc…
View article: Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study
Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH Study Open
LCP-tacrolimus displays enhanced oral bioavailability compared to immediate-release (IR-) tacrolimus. The ENVARSWITCH study aimed to compare tacrolimus AUC 0–24 h in stable kidney (KTR) and liver transplant recipients (LTR) on IR-tacrolimu…
View article: Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients
Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients Open
View article: In Reply to “Abdominal Pressure and Fluid Status After Kidney Transplantation”
In Reply to “Abdominal Pressure and Fluid Status After Kidney Transplantation” Open
View article: Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients
Early Administration of Anti–SARS-CoV-2 Monoclonal Antibodies Prevents Severe COVID-19 in Kidney Transplant Patients Open
View article: A Pilot Study on the Association Between Early Fluid Status Indicators After Kidney Transplantation and Graft Function Recovery
A Pilot Study on the Association Between Early Fluid Status Indicators After Kidney Transplantation and Graft Function Recovery Open
Progress in short-term kidney graft survival has decreased since 2000 which suggests an unmet need for innovation regarding early kidney graft function optimization.1 Previous studies have revealed that optimal perioperative fluid therapy …
View article: Changing of therapeutic trends between the 1st and 2nd wave did not reduce COVID-19 related mortality of renal transplant recipients: a national registry study
Changing of therapeutic trends between the 1st and 2nd wave did not reduce COVID-19 related mortality of renal transplant recipients: a national registry study Open
SARS-CoV-2 pandemic evolved in two consecutive waves over 2020 (for France: 1st wave from March 1 to July 31; and 2nd wave from August 1 to December 31). Improvements in the management of COVID-19 led to a reduction of mortality rates in h…
View article: Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients
Clinical Utility of Biochemical Markers for the Prediction of COVID-19−Related Mortality in Kidney Transplant Recipients Open
View article: Occurrence of severe COVID-19 in vaccinated transplant patients
Occurrence of severe COVID-19 in vaccinated transplant patients Open
View article: Is COVID-19 infection more severe in kidney transplant recipients?
Is COVID-19 infection more severe in kidney transplant recipients? Open
View article: IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)
IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT) Open
View article: Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort
Opportunistic Infections and Efficacy Following Conversion to Belatacept-Based Therapy after Kidney Transplantation: A French Multicenter Cohort Open
Conversion from calcineurin-inhibitors (CNIs) to belatacept can help kidney-transplant (KT) recipients avoid CNI-related nephrotoxicity. The risk of associated opportunistic infections (OPIs) is ill-defined. We conducted a multicentric coh…
View article: An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants Open
View article: Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome
Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome Open
Significance Statement Although complement blockade is highly effective for preventing recurrence of atypical hemolytic uremic syndrome (HUS) after kidney transplant, debates regarding the use of eculizumab prophylaxis continue because of …
View article: A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders
A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders Open
Background and objectives Post-transplant lymphoproliferative disorders arising after kidney transplantation portend an increased risk of morbidity and mortality. Retransplantation of patients who had developed post-transplant lymphoprolif…
View article: Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature
Plasma cell neoplasia after kidney transplantation: French cohort series and review of the literature Open
Although post-transplant lymphoproliferative disorder (PTLD) is the second most common type of cancer in kidney transplantation (KT), plasma cell neoplasia (PCN) occurs only rarely after KT, and little is known about its characteristics an…
View article: Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study
Kidney transplantation in patients with systemic sclerosis: a nationwide multicentre study Open
Kidney transplantation is one of the therapeutic options for end-stage renal disease (ESRD) in systemic sclerosis (SS). Current evidence demonstrates poorer patient and graft survival after transplantation in SS than in other primary kidne…
View article: Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients
Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients Open
Anti-tumor necrosis factor-α (TNFα) therapy has improved the prognosis of many chronic inflammatory diseases. It appears to be well-tolerated by liver-transplant patients. However, their use and their safety in kidney-transplant patients h…
View article: Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study
Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study Open
These results highlight that the diagnosis of bronchiectasis should be considered in patients with de novo respiratory symptoms after renal transplantation. Further studies are needed to more clearly understand the mechanisms underlying br…
View article: Eight-year results of the Spiesser study, a randomized trial comparing<i>de novo</i>sirolimus and cyclosporine in renal transplantation
Eight-year results of the Spiesser study, a randomized trial comparing<i>de novo</i>sirolimus and cyclosporine in renal transplantation Open
We present the results at 8 years of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in kidney transplant recipients at low immunologic risk. We assessed estimated glomerular filtration (eGFR), graft, pa…